Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · IEX Real-Time Price · USD
0.537
-0.024 (-4.36%)
Jun 20, 2024, 3:38 PM EDT - Market open

Ensysce Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year
Current20232022202120202019 2018 - 2017
Market Capitalization
43611478261
Upgrade
Market Cap Growth
--39.77%-95.14%46.40%-70.11%6.11%
Upgrade
Enterprise Value
13711982263
Upgrade
PE Ratio
-0.50-0.31-0.22-3.811371.67-25.79
Upgrade
PB Ratio
1.10-10.33-1.49-14.47-12.09-39.02
Upgrade
P/FCF Ratio
-0.55-0.31-0.31-13.83-62.43-278.53
Upgrade
P/OCF Ratio
-0.55-0.31-0.31-13.83-62.43-278.53
Upgrade
EV/EBITDA Ratio
-0.26-0.30-0.28-4.2877.86-28.74
Upgrade
EV/EBIT Ratio
-0.26-0.30-0.28-4.2877.88-28.74
Upgrade
EV/FCF Ratio
-0.25-0.28-0.38-14.43-65.70-280.97
Upgrade
Debt / Equity Ratio
0.07-2.65-1.19-2.19-0.66-0.39
Upgrade
Debt / EBITDA Ratio
-0.02-0.08-0.18-0.624.06-0.29
Upgrade
Debt / FCF Ratio
-0.02-0.08-0.25-2.09-3.42-2.80
Upgrade
Quick Ratio
2.140.370.360.770.030.07
Upgrade
Current Ratio
2.870.690.560.950.050.09
Upgrade
Interest Coverage
-6.21-28.99-219.70-21.451.06-9.53
Upgrade
Return on Equity (ROE)
-511.50%-780.20%1126.20%1213.10%2.70%-485.50%
Upgrade
Return on Assets (ROA)
-266.10%-262.40%-290.90%-327.40%0.30%-6.50%
Upgrade
Return on Capital (ROIC)
-250.31%-2015.31%-3365.91%-212.84%74.34%211.31%
Upgrade
Earnings Yield
-279.06%-318.64%-453.03%-26.22%0.07%-3.88%
Upgrade
FCF Yield
-255.73%-323.25%-322.96%-7.23%-1.60%-0.36%
Upgrade
Buyback Yield / Dilution
-440.17%-1158.34%-114.15%-22.15%33.68%-314.69%
Upgrade
Total Shareholder Return
-440.17%-1158.34%-114.15%-22.15%33.68%-314.69%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).